UNIVERSITY OF PITTSBURGH AT PITTSBURGH
Novel Biomarkers for Post-Liver Transplant NASH Fibrosis
Novel Biomarkers for Post-Liver Transplant NASH Fibrosis is a funding opportunity from UNIVERSITY OF PITTSBURGH AT PITTSBURGH, up to 697731, closing May 31, 2027.
May 31, 2027
(304d left)Overview
Our overarching goal is to develop minimally invasive approaches to better predict outcome and novel mechanisms in post-liver transplant (LT) NASH fibrosis. Although LT is an effective therapy for NAFLD cirrhosis, the risk of post-transplant NAFLD is alarmingly high, particularly for recurrent non-alcoholic…